Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Feature Stories

Latest Feature Stories

In the MSF Ebola Treatment Center in Guéckédou, Finda (left), and Kadia (right), two Ebola patients participating in the favipiravir trial, relax outside their ward. Inside, MSF staff care for a five year old boy whose mother died from Ebola the previous day. Photograph by Peter Casaer
Feature story
Feature story |
24 February 2015
Tropical & neglected diseases
Liberia

Ebola drug trial in Liberia halted

Measles vaccine is given to children from 6 months to 15 years. Hundreds of children pass through each vaccination site every day during the mass vaccination campaign. Photograph by Karin Ekholm
Feature story
Feature story |
18 February 2015
Vaccines
South Sudan

South Sudan: Fighting a measles outbreak in Yida refugee camp

4 min
2013 marked the first time that PCV is being used in South Sudan and one of the first vaccines to be implemented in compliance with the new WHO emergency vaccination recommendations. Photograph by Yann Libessart
Feature story
Feature story |
19 January 2015

MSF statement on accepting donations of the pneumococcal conjugate vaccine (PCV)

Beat the Bulldozers: Separating fake from life-saving generic medicines
Feature story
Feature story |
18 December 2014
Research and development
European Union

Protecting Generic Medicines in Transit Through the EU

Feature story |
08 December 2014
Research and development

Congress should fix the priority review voucher program: MSF’s Rius explains

6 min
Feature story |
26 August 2014
Vaccines
Ethiopia

Ethiopia: Tens of thousands of South Sudanese refugees receive cholera vaccine

4 min
A measles epidemic is spreading in the north of DRC, affecting ten of thousands of children. Photograph by Tristan Pfund
Feature story
Feature story |
25 July 2014
Vaccines
Democratic Republic of the Congo

MSF team vaccinated 38,000 children against measles in the Democratic Republic of Congo (DRC)

3 min
In Swaziland, 99 patients from Matsapha clinic and 35 from Mankayane hospital who had successfully completed their treatment for drug-resistant TB received honorary certificates from MSF saying, “I got tested and cured of TB”. Photograph by Audrey van der Schoot
Feature story
Feature story |
24 July 2014
Tuberculosis

Surviving drug-resistant TB in Swaziland: "I’m still over the moon”

5 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury